FRATINI, ALICE
FRATINI, ALICE
DIPARTIMENTO DI SCIENZE CLINICO-CHIRURGICHE, DIAGNOSTICHE E PEDIATRICHE
Baseline amino acid substitutions in the NS5A ISDR and PKR binding domain of hepatitis C and different fibrosis levels and levels of development of hepatocellular carcinoma in patients treated with DAAs
2020-01-01 Paolucci, S.; Piralla, A.; Novazzi, F.; Fratini, A.; Maserati, R.; Gulminetti, R.; Novati, S.; Barbarini, G.; Sacchi, P.; De Silvestri, A.; Baldanti, F.
Emergence of Letermovir-resistant HCMV UL56 mutant during rescue treatment in a liver transplant recipient with ganciclovir-resistant infection HCMV: a case report
2021-01-01 Paolucci, Stefania; Campanini, Giulia; Cassaniti, Irene; Tebaldi, Alessandra; Novazzi, Federica; Fratini, Alice; Meini, Antonella; Girelli, Federica; Palumbo, Laura; Plebani, Alessandro; Baldanti, Fausto
Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations
2019-01-01 Paolucci, S.; Novazzi, F.; Piralla, A.; Maserati, R.; Gulminetti, R.; Novati, S.; Barbarini, G.; Sacchi, P.; Fratini, A.; Bellotti, L.; Baldanti, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Baseline amino acid substitutions in the NS5A ISDR and PKR binding domain of hepatitis C and different fibrosis levels and levels of development of hepatocellular carcinoma in patients treated with DAAs | 1-gen-2020 | Paolucci, S.; Piralla, A.; Novazzi, F.; Fratini, A.; Maserati, R.; Gulminetti, R.; Novati, S.; Barbarini, G.; Sacchi, P.; De Silvestri, A.; Baldanti, F. | |
| Emergence of Letermovir-resistant HCMV UL56 mutant during rescue treatment in a liver transplant recipient with ganciclovir-resistant infection HCMV: a case report | 1-gen-2021 | Paolucci, Stefania; Campanini, Giulia; Cassaniti, Irene; Tebaldi, Alessandra; Novazzi, Federica; Fratini, Alice; Meini, Antonella; Girelli, Federica; Palumbo, Laura; Plebani, Alessandro; Baldanti, Fausto | |
| Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations | 1-gen-2019 | Paolucci, S.; Novazzi, F.; Piralla, A.; Maserati, R.; Gulminetti, R.; Novati, S.; Barbarini, G.; Sacchi, P.; Fratini, A.; Bellotti, L.; Baldanti, F. |